0001493152-20-011545.txt : 20200619
0001493152-20-011545.hdr.sgml : 20200619
20200619173716
ACCESSION NUMBER: 0001493152-20-011545
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200617
FILED AS OF DATE: 20200619
DATE AS OF CHANGE: 20200619
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Redmond Cavan M.
CENTRAL INDEX KEY: 0001420120
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37648
FILM NUMBER: 20976656
MAIL ADDRESS:
STREET 1: 5 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoCyte Corp
CENTRAL INDEX KEY: 0001642380
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 271041563
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-409-7600
MAIL ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Oncocyte Corp
DATE OF NAME CHANGE: 20200205
FORMER COMPANY:
FORMER CONFORMED NAME: OncoCyte Corp
DATE OF NAME CHANGE: 20150513
4
1
ownership.xml
X0306
4
2020-06-17
0
0001642380
OncoCyte Corp
OCX
0001420120
Redmond Cavan M.
C/O ONCOCYTE CORPORATION
15 CUSHING
IRVINE
CA
92618
1
0
0
0
Option to purchase common stock
2.38
2020-06-17
4
A
0
62000
0
A
Common Stock
62000
62000
D
Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
/s/ Cavan Redmond
2020-06-19